Ana Ferreira

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

Joaquı́n Mateo, Núria Porta, Diletta Bianchini et al. · The Lancet Oncology · 2019 · 644 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

Alec Paschalis, Beshara Sheehan, Ruth Riisnaes et al. · European Urology · 2019 · 465 citations · Full text

Medicine, Oncology, Urology +17

IL-23 secreted by myeloid cells drives castration-resistant prostate cancer

Arianna Calcinotto, Clarissa Spataro, Elena Zagato et al. · Nature · 2018 · 388 citations

Medicine, Immunology, Oncology +14

Targeting the p300/CBP Axis in Lethal Prostate Cancer

Jonathan Welti, Adam Sharp, Nigel Brooks et al. · Cancer Discovery · 2021 · 284 citations · Full text

Medicine, Molecular Biology, Oncology +17

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer

Daniel Nava Rodrigues, Pasquale Rescigno, David Liu et al. · Journal of Clinical Investigation · 2018 · 209 citations · Full text

Medicine, Immunology, Oncology +17